FRIDAY 11 OCTOBER 2019 | 10th Trends in Medical Mycology

09:00

ECMM council meeting

12:00

Coffee break

12:30

Welcome address

12:45

Plenary Session 1 - Tropical

12:45

PS1.1 Histoplasmosis

Matthieu Nacher, France

13:15

PS 1.2 Emergomycosis

Nelesh Govender, FECMM, South Africa

Parallel Symposia 1-4

Symposium 1 Water quality (mis-)management – an opportunity for fungal contamination

13:45

S01.1 Fungal contaminants in drinking water regulation? A tale of ecology, exposure, purification and clinical relevance

Monica Novak Babič, Slovenia

14:05

S01.2 Hospital environment: water supply and containment of aerosolised fungal particles. How far must we go in times of antimicrobial resistance?

Raquel Sabino, FECMM, Portugal

14:25

S01.3 Potential transmission pathways of clinically relevant fungi in indoor swimming pool facilities.

Ciska Schets, the Netherlands

14:45

S01.4* Study of fungal environmental contamination in nests of the penguin enclosure of a large French animal zoo park.

Guillaume Desoubeaux, France

14:55

S01.5* Spectrum of indoor fungi isolated from indoor environments in Busia-Kenya

Olga Mashedi, Kenya

Symposium 2 Pneumocystis jirovecii, an airborne transmissible and human derived ascomycete showing strong pulmonary tropism

13:45

S02.1 Pneumocystis jirovecii: an obligate parasite of human lungs with unique camouflage and sex strategies

Philippe Hauser, Switzerland

14:05

S02.2 High-throughput methodologies in molecular epidemiology of Pneumocystis jirovecii

Olga Matos, Portugal

14:25

S02.3 Airborne acquisition and transmission of Pneumocystis jirovecii: an update

Gilles Nevez, France

14:45

S02.4

To be confirmed

15:05

S02.5* Does Pneumocystis jiroveci infection aggravate the prognosis of invasive pulmonary aspergillosis? Data from the RESSIF network in France (2012-2016)

Florence Robert-Gangneux, France

Symposium 3 Mucormycosis

13:45

S03.1 Hospital related mucormycosis

Anna Skiada, Greece

14:00

S03.3 The new treatment of mucormycosis

Livio Pagano, FECMM, Italy

14:15

S03.4 Clinical features associated to fungal species

Dea Garcia Hermoso, France

14:30

S03.5 Molecular diagnosis

Laurence Millon, France

14:45

S03.6 Management of mucormycosis in low and middle income countries

Arunaloke Chakrabarti, FECMM, India

15:00

Discussion

Symposium 4 MSG symposium (Trial Design in Clinical Mycology: Innovative Approaches)

13:45

S04.1 Candidiasis

Bart-Jan Kullberg, the Netherlands

14:05

S04.2 Endemic Mycoses

George Thompson, USA

14:25

S04.3 Cryptococcosis

David Boulware, USA

14:45

S04.4 Aspergillosis and other molds

Tom Patterson, USA

15:05

S04.5* The lung transplant community is interested in a clinical trial to determine the optimal strategy to prevent invasive mold disease

Ricardo La Hoz, USA

Coffee break

15:15

15:30